Since the discovery that neural progenitor cells (NPCs) from induced pluripotent stem cells (iPSCs) can proliferate or differentiate into neurons, oligodendrocytes, or astrocytes, the use of neural stem cells in research and medicine has become increasingly widespread.
ATCC NPCs are derived from a collection of well-characterized, integration-free reprogrammed iPSCs. For investigators looking to reduce the time from initial culture to experiment readout, our NPCs can eliminate the 4 to 8 weeks for iPSCs to differentiate into NPCs.
ATCC provides a complete system of NPC solutions for investigating development, degeneration and regeneration, neurogenetics, neural excitability, nervous system disorders, neurotransmitters, and screening therapeutics.
- Normal and Parkinson’s disease iPSC-derived NPCs
- Gene-edited, lineage-specific reporter NPCs
- Expansion and differentiation media kits
- Validated growth and differentiation protocols
Learn more: Neural Progenitor Stem Cells | ATCC